ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry

Host cell proteins (HCPs) must be adequately removed from recombinant therapeutics by downstream processing to ensure patient safety, product quality, and regulatory compliance. HCP process clearance is typically monitored by enzyme-linked immunosorbent assay (ELISA) using a polyclonal reagent. Rece...

Full description

Saved in:
Bibliographic Details
Published in:MAbs
Main Authors: Henry, Scott M., Sutlief, Elissa, Salas-Solano, Oscar, Valliere-Douglass, John
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2017
Subjects:
Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5627587/
https://ncbi.nlm.nih.gov/pubmed/28708446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2017.1349586
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items